Samsara Bio Capital, LLC Pds Biotechnology Corp Transaction History
Samsara Bio Capital, LLC
- $173 Million
- Q3 2024
Shares
2 transactions
Others Institutions Holding PDSB
# of Institutions
64Shares Held
4.32MCall Options Held
253KPut Options Held
70.4K-
Vanguard Group Inc Valley Forge, PA1.52MShares$3.18 Million0.0% of portfolio
-
Black Rock Inc. New York, NY487KShares$1.02 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA415KShares$867,5860.0% of portfolio
-
Inspirion Wealth Advisors, LLC344KShares$719,7830.18% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny234KShares$489,4960.0% of portfolio
About PDS Biotechnology Corp
- Ticker PDSB
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 28,458,700
- Market Cap $59.5M
- Description
- PDS Biotechnology Corporation, a clinical-stage biopharmaceutical company, focuses on developing multifunctional cancer immunotherapies. Its lead product candidate is PDS0101 (HPV16), which is in Phase II clinical trial provides a first line treatment for the recurrent/metastatic head and neck cancer, human papillomavirus associated malignancies...